NRXP

NRx Pharmaceuticals, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$2.28

Price (1 Year)

$4.42 $1.7

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0.9 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %0.5 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments.

Website

Analysis (Turkish): NRXP Hissesi Caiz mi, Helal mi? NRx Pharmaceuticals, Inc. Katılım Analizi